Back to Results
First PageMeta Content
Staphylococcaceae / Bacterial diseases / Infective endocarditis / Valvular heart disease / Staphylococcus aureus / Staphylococcus / Healthcare Cost and Utilization Project / Enterococcus / Targanta Therapeutics Corporation / Bacteria / Gram-positive bacteria / Microbiology


Moderate-Risk Tumor A Patients Receiving Curative Therapy, % 90
Add to Reading List

Open Document

File Size: 194,34 KB

Share Result on Facebook
UPDATE